Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Denial, Hate, and Silence: The Three Responses to Overwhelming Evidence of Canada’s Campus Antisemitism Crisis 
The Law Bytes Podcast, Episode 278: Ben Waldman on Gander Social and the Challenges of Building a Sovereign Social Network 
Canada’s Campus Antisemitism Crisis: National Survey Finds Antisemitism Nearly Everywhere and University Responses Nowhere 
Why the Answers to Hateful Content Online are Hiding in the Platforms’ Own Rules 
From CCH to ChatGPT: How Canadian Copyright Law Played the Key Role in Deciding a Leading AI Training Data Case in India
